CEO, Sofia Hurtado, is attending the startup fellowship at UT Austin Mccomb's School of Business Brumley Institute of Graduate Entrepreneurship. She is representing Saight as a Founder in Residence and recieving business training through the associated SEAL program.

Saight completed the National Science Foundation’s I-CORPS program, a highly selective initiative supporting research-driven startups in validating product–market fit. As part of the program, our team conducted 100+ structured customer discovery interviews with Gastroenterologists, Ambulatory Surgery Center Leaders, Endoscope Manufacturers, Health Insurance Representatives, and Healthcare stakeholders, to inform commercialization and deployment. CEO, Sofia Hurtado attended five conferences spanning gastroenerology, endoscopic surgery, health tech and medical billing to perform customer discovery.

Our team was invited to pitch at UT Austin’s Discovery to Impact Venture Showcase, highlighting Saight among the university’s most promising startups. Media coverage featured a quote from our CEO, underscoring our real-world progress and our commitment to translating next-generation research into scalable clinical impact.

The research powering Saight’s technology is making headlines. CTO-designate Radu Marculescu and Lead Scientific Developer Md Mostafijur Rahman unveiled AI breakthroughs that bring ultra-fast, resource-lean 3D imaging straight to the patient’s bedside.
